ciprofloxacin has been researched along with Leucocythaemia in 37 studies
Ciprofloxacin: A broad-spectrum antimicrobial carboxyfluoroquinoline.
ciprofloxacin : A quinolone that is quinolin-4(1H)-one bearing cyclopropyl, carboxylic acid, fluoro and piperazin-1-yl substituents at positions 1, 3, 6 and 7, respectively.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This intervention influenced administration of ciprofloxacin without apparent compromise of patient outcomes and resulted in a reduction in total costs of treating febrile neutropenia." | 9.09 | A new ciprofloxacin stepdown program in the treatment of high-risk febrile neutropenia: a clinical and economic analysis. ( de Lemos, ML; Frighetto, L; Jewesson, PJ; Marra, CA; Marra, F; Quaia, CB; Warkentin, DI, 2000) |
| "To assess the efficacy of ciprofloxacin in neutropenic patients, we conducted a randomized prospective trial comparing the combination of ciprofloxacin and netilmicin against piperacillin plus netilmicin as an empiric treatment of fever in cancer patients with neutropenia." | 9.06 | Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patients. ( Anderson, H; Chan, CC; Oppenheim, BA; Scarffe, JH; Swindell, R, 1989) |
| "Ciprofloxacin, a new quinolone derivative, was given prophylactically (500 mg twice daily) to 15 patients with acute leukemia during remission induction treatment." | 9.06 | Ciprofloxacin for infection prevention in patients with acute leukemia. ( Dekker, AW; Rozenberg-Arska, M, 1987) |
| "Fifty-six patients receiving remission induction treatment for acute leukemia were studied in a randomized trial comparing ciprofloxacin with trimethoprim-sulfamethoxazole plus colistin for prevention of infections." | 9.06 | Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. ( Dekker, AW; Rozenberg-Arska, M; Verhoef, J, 1987) |
| "The current results suggest that fluoroquinolone prophylaxis for patients with febrile neutropenia may be abandoned safely in areas with a high prevalence of ciprofloxacin-resistant enterobacteria." | 7.72 | Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli. ( Dalmau, D; Estany, C; Estrada, C; Garau, J; Gomez, L; Marquez, M; Martí, JM; Xercavins, M, 2003) |
| "The current study demonstrates that very carefully selected, low risk patients with febrile neutropenia may be treated successfully without hospitalization using oral ciprofloxacin." | 7.70 | Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer. ( Aquino, VM; Buchanan, GR; Herrera, L; Sandler, ES, 2000) |
| "We studied the efficacy of piperacillin and ciprofloxacin as initial parenteral therapy in 41 adult patients with leukemia who developed 47 febrile episodes during severe neutropenia following chemotherapy." | 7.68 | A pilot study of piperacillin and ciprofloxacin as initial therapy for fever in severely neutropenic leukemia patients. ( Lerner, R; Nilsson, PG; Palmblad, J; Samuelsson, J; Wahlin, A; Winqvist, I, 1992) |
| "Ciprofloxacin, a new quinolone derivative, was given prophylactically (500 mg twice a day) to 15 patients with acute leukemia during remission induction treatment for a mean duration of 42 days." | 7.67 | Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora. ( Dekker, AW; Rozenberg-Arska, M; Verhoef, J, 1985) |
| "In a randomized study comparing cotrimoxazole plus colistin with ciprofloxacin, each in combination with nonabsorbable antimycotics, the incidence of major infections in terms of septicemias and pneumonias as well as of minor infections and episodes of unexplained fever (FUO) was higher in patients treated with ciprofloxacin." | 6.16 | Prevention of infection in acute leukemia. ( Daenen, S; de Pauw, BE; de Vries-Hospers, HG; Dekker, AW; Donnelly, JP; Gaus, W; Haralambie, E; Kern, W; Konrad, H; Maschmeyer, G, 1990) |
| "To determine whether ciprofloxacin-piperacillin is equivalent to tobramycin-piperacillin as empirical therapy for neutropenic fever." | 5.10 | Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial. ( Cushing, DA; Donowitz, GR; Harman, CP; Haverstock, DC; Herrington, DA; Hurd, DD; Kowalsky, SF; Lazarus, HM; Peacock, JE; Reed, MD; Sinclair, JW; Wade, JC, 2002) |
| "This intervention influenced administration of ciprofloxacin without apparent compromise of patient outcomes and resulted in a reduction in total costs of treating febrile neutropenia." | 5.09 | A new ciprofloxacin stepdown program in the treatment of high-risk febrile neutropenia: a clinical and economic analysis. ( de Lemos, ML; Frighetto, L; Jewesson, PJ; Marra, CA; Marra, F; Quaia, CB; Warkentin, DI, 2000) |
| "More patients receiving ciprofloxacin did not develop fever during neutropenia and did not receive antibiotics (34%) compared with those receiving norfloxacin (25%) (P = 0." | 5.07 | Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. ( , 1991) |
| "To assess the efficacy of ciprofloxacin in neutropenic patients, we conducted a randomized prospective trial comparing the combination of ciprofloxacin and netilmicin against piperacillin plus netilmicin as an empiric treatment of fever in cancer patients with neutropenia." | 5.06 | Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patients. ( Anderson, H; Chan, CC; Oppenheim, BA; Scarffe, JH; Swindell, R, 1989) |
| "Ciprofloxacin, a new quinolone derivative, was given prophylactically (500 mg twice daily) to 15 patients with acute leukemia during remission induction treatment." | 5.06 | Ciprofloxacin for infection prevention in patients with acute leukemia. ( Dekker, AW; Rozenberg-Arska, M, 1987) |
| "Fifty-six patients receiving remission induction treatment for acute leukemia were studied in a randomized trial comparing ciprofloxacin with trimethoprim-sulfamethoxazole plus colistin for prevention of infections." | 5.06 | Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin. ( Dekker, AW; Rozenberg-Arska, M; Verhoef, J, 1987) |
| "The current results suggest that fluoroquinolone prophylaxis for patients with febrile neutropenia may be abandoned safely in areas with a high prevalence of ciprofloxacin-resistant enterobacteria." | 3.72 | Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli. ( Dalmau, D; Estany, C; Estrada, C; Garau, J; Gomez, L; Marquez, M; Martí, JM; Xercavins, M, 2003) |
| "The current study demonstrates that very carefully selected, low risk patients with febrile neutropenia may be treated successfully without hospitalization using oral ciprofloxacin." | 3.70 | Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer. ( Aquino, VM; Buchanan, GR; Herrera, L; Sandler, ES, 2000) |
| "We studied the efficacy of piperacillin and ciprofloxacin as initial parenteral therapy in 41 adult patients with leukemia who developed 47 febrile episodes during severe neutropenia following chemotherapy." | 3.68 | A pilot study of piperacillin and ciprofloxacin as initial therapy for fever in severely neutropenic leukemia patients. ( Lerner, R; Nilsson, PG; Palmblad, J; Samuelsson, J; Wahlin, A; Winqvist, I, 1992) |
| "Ciprofloxacin, a new quinolone derivative, was given prophylactically (500 mg twice a day) to 15 patients with acute leukemia during remission induction treatment for a mean duration of 42 days." | 3.67 | Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora. ( Dekker, AW; Rozenberg-Arska, M; Verhoef, J, 1985) |
| "Forty-six episodes of fever in 34 patients with neutropenia and haematological malignancy were treated empirically with a combination of ciprofloxacin and vancomycin." | 3.67 | A clinical, microbiological and pharmacokinetic study of ciprofloxacin plus vancomycin as initial therapy of febrile episodes in neutropenic patients. ( Farrell, ID; Geddes, AM; Leyland, MJ; Smith, GM, 1988) |
| "Twenty-four episodes of fever in neutropenic patients with haematological malignancy were treated with ciprofloxacin." | 3.67 | Preliminary evaluation of ciprofloxacin, a new 4-quinolone antibiotic, in the treatment of febrile neutropenic patients. ( Farrell, ID; Geddes, AM; Leyland, MJ; Smith, GM, 1986) |
| "Ciprofloxacin was therefore superior to the other two fluoroquinolones in preventing infections due to Gram-negative bacteria in this population of neutropenic patients." | 2.67 | Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies. ( Accorsi, P; Betti, S; D'Antonio, D; Dell'Isola, M; Favalli, C; Fioritoni, G; Iacone, A; Parruti, G; Piccolomini, R; Quaglietta, AM, 1994) |
| "Ciprofloxacin was associated with a low incidence of adverse events with skin rash (five cases) and nausea (one case) being reported as possibly or probably related to ciprofloxacin." | 2.67 | High dose intravenous ciprofloxacin in febrile neutropenic patients. ( Johnson, PR; Tooth, JA; Yin, JA, 1990) |
| "Patients who are treated for acute leukemia should be offered prophylaxis with ciprofloxacin or levofloxacin." | 2.43 | Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions. ( Bucaneve, G; Cullen, M; Fraser, A; Gafter-Gvili, A; Kern, WV; Leibovici, L; Paul, M, 2006) |
| "Ciprofloxacin was withdrawn from use in the unit and daily bathing with chlorhexidine gluconate solution started." | 1.28 | Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit. ( Burnie, JP; Hartley, JW; Lee, W; Oppenheim, BA, 1989) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (35.14) | 18.7374 |
| 1990's | 13 (35.14) | 18.2507 |
| 2000's | 9 (24.32) | 29.6817 |
| 2010's | 2 (5.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hallböök, H | 1 |
| Lidström, AK | 1 |
| Pauksens, K | 1 |
| Michels, G | 1 |
| Pfister, R | 1 |
| Kochanek, M | 1 |
| Shimabukuro-Vornhagen, A | 1 |
| Peacock, JE | 1 |
| Herrington, DA | 1 |
| Wade, JC | 1 |
| Lazarus, HM | 1 |
| Reed, MD | 1 |
| Sinclair, JW | 1 |
| Haverstock, DC | 1 |
| Kowalsky, SF | 1 |
| Hurd, DD | 1 |
| Cushing, DA | 1 |
| Harman, CP | 1 |
| Donowitz, GR | 1 |
| Gomez, L | 1 |
| Garau, J | 1 |
| Estrada, C | 1 |
| Marquez, M | 1 |
| Dalmau, D | 1 |
| Xercavins, M | 1 |
| Martí, JM | 1 |
| Estany, C | 1 |
| Paganini, H | 1 |
| Gómez, S | 1 |
| Ruvinsky, S | 1 |
| Zubizarreta, P | 1 |
| Latella, A | 1 |
| Fraquelli, L | 1 |
| Iturres, AS | 1 |
| Casimir, L | 1 |
| Debbag, R | 1 |
| Leibovici, L | 1 |
| Paul, M | 1 |
| Cullen, M | 1 |
| Bucaneve, G | 2 |
| Gafter-Gvili, A | 1 |
| Fraser, A | 1 |
| Kern, WV | 1 |
| Borlenghi, E | 1 |
| Cattaneo, C | 1 |
| Capucci, MA | 1 |
| Pan, A | 1 |
| Quaresmini, G | 1 |
| Franco, F | 1 |
| Grazioli, L | 1 |
| Carosi, GP | 1 |
| Rossi, G | 1 |
| Ketley, NJ | 1 |
| Kelsey, SM | 1 |
| Newland, AC | 2 |
| D'Antonio, D | 3 |
| Piccolomini, R | 1 |
| Iacone, A | 2 |
| Fioritoni, G | 2 |
| Parruti, G | 1 |
| Betti, S | 2 |
| Quaglietta, AM | 1 |
| Accorsi, P | 1 |
| Dell'Isola, M | 2 |
| Favalli, C | 1 |
| Cornelissen, JJ | 1 |
| Rozenberg-Arska, M | 6 |
| Dekker, AW | 6 |
| Sakamoto, M | 2 |
| Saruta, K | 1 |
| Nakazawa, Y | 1 |
| Shindo, N | 1 |
| Maezawa, H | 1 |
| Yoshikawa, K | 1 |
| Yoshida, M | 1 |
| Shiba, K | 1 |
| Sakai, O | 1 |
| Saito, A | 1 |
| Aquino, VM | 1 |
| Herrera, L | 1 |
| Sandler, ES | 1 |
| Buchanan, GR | 1 |
| Marra, CA | 1 |
| Frighetto, L | 1 |
| Quaia, CB | 1 |
| de Lemos, ML | 1 |
| Warkentin, DI | 1 |
| Marra, F | 1 |
| Jewesson, PJ | 1 |
| Uphoff, CC | 2 |
| Meyer, C | 1 |
| Drexler, HG | 3 |
| Gignac, SM | 2 |
| Samuelsson, J | 1 |
| Nilsson, PG | 1 |
| Wahlin, A | 1 |
| Lerner, R | 1 |
| Winqvist, I | 1 |
| Palmblad, J | 1 |
| Pizzigallo, E | 1 |
| Piergallini, A | 1 |
| Di Gianfilippo, R | 1 |
| Olioso, P | 1 |
| Torlontano, G | 1 |
| Brauer, S | 1 |
| Häne, B | 1 |
| Quentmeier, H | 1 |
| Maschmeyer, G | 1 |
| Daenen, S | 1 |
| de Pauw, BE | 1 |
| de Vries-Hospers, HG | 1 |
| Donnelly, JP | 1 |
| Gaus, W | 1 |
| Haralambie, E | 1 |
| Kern, W | 1 |
| Konrad, H | 1 |
| Johnson, PR | 1 |
| Yin, JA | 1 |
| Tooth, JA | 1 |
| Verdonck, LF | 1 |
| Oppenheim, BA | 2 |
| Hartley, JW | 1 |
| Lee, W | 1 |
| Burnie, JP | 1 |
| Del Favero, A | 1 |
| Martino, P | 1 |
| Micozzi, A | 1 |
| Minetti, B | 1 |
| Ricci, P | 1 |
| Landonio, G | 1 |
| Montillo, M | 1 |
| Malleo, C | 1 |
| Chan, CC | 1 |
| Anderson, H | 1 |
| Swindell, R | 1 |
| Scarffe, JH | 1 |
| Somekh, E | 1 |
| Douer, D | 1 |
| Shaked, N | 1 |
| Rubinstein, E | 1 |
| Azadian, BS | 1 |
| Bendig, JW | 1 |
| Samson, DM | 1 |
| Verhoef, J | 3 |
| Dekker, A | 1 |
| Dennig, D | 1 |
| Fülle, HH | 1 |
| Hellriegel, KP | 1 |
| Wood, ME | 1 |
| Smith, GM | 2 |
| Leyland, MJ | 2 |
| Farrell, ID | 2 |
| Geddes, AM | 2 |
2 reviews available for ciprofloxacin and Leucocythaemia
| Article | Year |
|---|---|
Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions.
Topics: Acute Disease; Antibiotic Prophylaxis; Antineoplastic Agents; Bone Marrow Transplantation; Ciproflox | 2006 |
Prevention of infection in acute leukemia.
Topics: Acute Disease; Anti-Bacterial Agents; Ciprofloxacin; Colistin; Drug Therapy, Combination; Humans; In | 1990 |
14 trials available for ciprofloxacin and Leucocythaemia
| Article | Year |
|---|---|
Ciprofloxacin plus piperacillin compared with tobramycin plus piperacillin as empirical therapy in febrile neutropenic patients. A randomized, double-blind trial.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bone Marrow Transplant | 2002 |
Outpatient, sequential, parenteral-oral antibiotic therapy for lower risk febrile neutropenia in children with malignant disease: a single-center, randomized, controlled trial in Argentina.
Topics: Administration, Oral; Adolescent; Ambulatory Care; Amikacin; Anti-Bacterial Agents; Antineoplastic A | 2003 |
Comparison of ciprofloxacin, ofloxacin and pefloxacin for the prevention of the bacterial infection in neutropenic patients with haematological malignancies.
Topics: Adult; Aged; Agranulocytosis; Anti-Infective Agents; Bacteremia; Bacterial Infections; Ciprofloxacin | 1994 |
Discontinuation of intravenous antibiotic therapy during persistent neutropenia in patients receiving prophylaxis with oral ciprofloxacin.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Ciprofloxacin; Fever of Unknown | 1995 |
Sepsis associated with hematological malignancies: prophylaxis of Pseudomonas aeruginosa sepsis.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antibiotic Prophylaxis; Bacteremia; Ciprofloxacin; Drug | 1996 |
A new ciprofloxacin stepdown program in the treatment of high-risk febrile neutropenia: a clinical and economic analysis.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Ciprofloxacin; Costs and Cost Analysis; Female; | 2000 |
Prevention of bacterial infection in neutropenic patients with hematologic malignancies. A randomized, multicenter trial comparing norfloxacin with ciprofloxacin. The GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Ciprofloxacin; Female; Fever; | 1991 |
Prevention of infection in acute leukemia.
Topics: Acute Disease; Anti-Bacterial Agents; Ciprofloxacin; Colistin; Drug Therapy, Combination; Humans; In | 1990 |
High dose intravenous ciprofloxacin in febrile neutropenic patients.
Topics: Adolescent; Adult; Aged; Bacterial Infections; Ciprofloxacin; Female; Fever; Gram-Negative Bacteria; | 1990 |
[Prophylaxis using quinolones in neutropenic patients. Preliminary results of a cooperative study by the Grupo Italiano Malattie Ematologiche maligne dell'adulto (GIMEMEA)].
Topics: Agranulocytosis; Anti-Bacterial Agents; Bacterial Infections; Bone Marrow Transplantation; Ciproflox | 1989 |
Randomized trial comparing ciprofloxacin plus netilmicin versus piperacillin plus netilmicin for empiric treatment of fever in neutropenic patients.
Topics: Administration, Oral; Adolescent; Adult; Aged; Agranulocytosis; Bacterial Infections; Bone Marrow Tr | 1989 |
Prevention of infection in patients with acute nonlymphocytic leukemia by several drug treatment regimens.
Topics: Acute Disease; Adult; Anti-Infective Agents; Ciprofloxacin; Clinical Trials as Topic; Colistin; Drug | 1987 |
Ciprofloxacin for infection prevention in patients with acute leukemia.
Topics: Adult; Bacterial Infections; Ciprofloxacin; Clinical Trials as Topic; Colistin; Drug Combinations; D | 1987 |
Infection prophylaxis in acute leukemia: a comparison of ciprofloxacin with trimethoprim-sulfamethoxazole and colistin.
Topics: Acute Disease; Agranulocytosis; Bacterial Infections; Ciprofloxacin; Colistin; Drug Combinations; Dr | 1987 |
22 other studies available for ciprofloxacin and Leucocythaemia
| Article | Year |
|---|---|
Ciprofloxacin prophylaxis delays initiation of broad-spectrum antibiotic therapy and reduces the overall use of antimicrobial agents during induction therapy for acute leukaemia: A single-centre study.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteremia; Bacterial Infections; Carbapenems | 2016 |
[53-year-old woman with life-threatening complications after use of ciprofloxacin and posaconazol].
Topics: Anti-Infective Agents; Cardiopulmonary Resuscitation; Ciprofloxacin; Electrocardiography; Female; Hu | 2012 |
Summaries for patients. Treatment of fever in hospitalized patients with low white blood cell counts.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Anti-Infective Agents; Bone Marrow Transplant | 2002 |
Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli.
Topics: Acute Disease; Adult; Aged; Anti-Infective Agents; Antibiotic Prophylaxis; Bacteremia; Ciprofloxacin | 2003 |
Usefulness of the MSG/IFICG/EORTC diagnostic criteria of invasive pulmonary aspergillosis in the clinical management of patients with acute leukaemia developing pulmonary infiltrates.
Topics: Acute Disease; Adult; Aged; Antifungal Agents; Aspergillosis, Allergic Bronchopulmonary; Ciprofloxac | 2007 |
Teicoplanin and oral ciprofloxacin as outpatient treatment of infective episodes in patients with indwelling central venous catheters and haematological malignancy.
Topics: Administration, Oral; Adolescent; Adult; Ambulatory Care; Bacterial Infections; Catheterization, Cen | 1995 |
[Optimal antibacterial chemotherapy for infectious diseases associated with hematological malignancies].
Topics: Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Bacterial Infections; Ciprofloxacin; Drug Therapy, | 1997 |
Feasibility of oral ciprofloxacin for the outpatient management of febrile neutropenia in selected children with cancer.
Topics: Administration, Oral; Adolescent; Adult; Ambulatory Care; Anti-Infective Agents; Blood Cell Count; C | 2000 |
Elimination of mycoplasma from leukemia-lymphoma cell lines using antibiotics.
Topics: Algorithms; Anti-Bacterial Agents; Anti-Infective Agents; Cell Culture Techniques; Ciprofloxacin; Cu | 2002 |
Mycoplasma contamination in human leukemia cell lines. II. Elimination with various antibiotics.
Topics: Anti-Bacterial Agents; Cell Division; Cell Line; Ciprofloxacin; Diterpenes; Drug Resistance, Microbi | 1992 |
A pilot study of piperacillin and ciprofloxacin as initial therapy for fever in severely neutropenic leukemia patients.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Ciprofloxacin; Drug Therapy, Combination; Dru | 1992 |
Occurrence of bacteremia in hematologic patients.
Topics: Adolescent; Adult; Aged; Bacteremia; Bone Marrow Transplantation; Catheterization; Ciprofloxacin; Fe | 1992 |
Elimination of mycoplasma from infected leukemia cell lines.
Topics: Cell Line; Ciprofloxacin; Decontamination; Fluorescent Antibody Technique; Humans; In Vitro Techniqu | 1991 |
Prevention of bacteremias caused by alpha-hemolytic streptococci by roxithromycin in patients treated with intensive cytotoxic treatment.
Topics: Acute Disease; Adult; Agranulocytosis; Amphotericin B; Antineoplastic Combined Chemotherapy Protocol | 1990 |
Outbreak of coagulase negative staphylococcus highly resistant to ciprofloxacin in a leukaemia unit.
Topics: Cancer Care Facilities; Ciprofloxacin; Coagulase; Cross Infection; Disease Outbreaks; Drug Resistanc | 1989 |
In vitro effects of ciprofloxacin and pefloxacin on growth of normal human hematopoietic progenitor cells and on leukemic cell lines.
Topics: Cell Division; Ciprofloxacin; Hematopoietic Stem Cells; Humans; Leukemia; Pefloxacin; Tumor Cells, C | 1989 |
Emergence of ciprofloxacin-resistant Pseudomonas aeruginosa after combined therapy with ciprofloxacin and amikacin.
Topics: Adult; Amikacin; Ciprofloxacin; Drug Resistance, Microbial; Drug Therapy, Combination; Female; Human | 1986 |
Ciprofloxacin for selective decontamination of the alimentary tract in patients with acute leukemia during remission induction treatment: the effect on fecal flora.
Topics: Acinetobacter; Acute Disease; Adult; Bacterial Infections; Bacteroides; Ciprofloxacin; Clostridium; | 1985 |
Chemoprophylaxis of bacterial infections in granulocytopenic patients with ciprofloxacin.
Topics: Adult; Aged; Aged, 80 and over; Agranulocytosis; Antineoplastic Agents; Bacterial Infections; Ciprof | 1987 |
Ciprofloxacin: initial evaluation in immunocompromised patients.
Topics: Antineoplastic Agents; Bacterial Infections; Bone Marrow Transplantation; Ciprofloxacin; Humans; Imm | 1987 |
A clinical, microbiological and pharmacokinetic study of ciprofloxacin plus vancomycin as initial therapy of febrile episodes in neutropenic patients.
Topics: Adolescent; Adult; Aged; Agranulocytosis; Ciprofloxacin; Drug Therapy, Combination; Fever; Humans; L | 1988 |
Preliminary evaluation of ciprofloxacin, a new 4-quinolone antibiotic, in the treatment of febrile neutropenic patients.
Topics: Adult; Aged; Agranulocytosis; Bacterial Infections; Ciprofloxacin; Female; Fever; Half-Life; Humans; | 1986 |